Head to Head Contrast: Unicharm (OTCMKTS:UNICY) vs. BioHarvest Sciences (NASDAQ:BHST)

BioHarvest Sciences (NASDAQ:BHST) and Unicharm (OTCMKTS:UNICY) are both consumer staples companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, institutional ownership, risk, dividends, earnings and profitability.

Earnings & Valuation

This table compares BioHarvest Sciences and Unicharm”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BioHarvest Sciences	$34.51 million	1.20	-$11.14 million	($0.59)	-3.58
Unicharm	$6.32 billion	1.75	$436.93 million	$0.13	24.46

Unicharm has higher revenue and earnings than BioHarvest Sciences. BioHarvest Sciences is trading at a lower price-to-earnings ratio than Unicharm, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares BioHarvest Sciences and Unicharm’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
BioHarvest Sciences	-32.54%	-76.03%	-25.30%
Unicharm	6.65%	7.15%	5.25%

Risk and Volatility

BioHarvest Sciences has a beta of 0.98, suggesting that its share price is 2% less volatile than the S&P 500. Comparatively, Unicharm has a beta of 0.31, suggesting that its share price is 69% less volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for BioHarvest Sciences and Unicharm, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BioHarvest Sciences	1	0	1	0	2.00
Unicharm	0	1	0	1	3.00

BioHarvest Sciences presently has a consensus target price of $10.00, indicating a potential upside of 373.93%. Given BioHarvest Sciences’ higher probable upside, analysts plainly believe BioHarvest Sciences is more favorable than Unicharm.

Summary

Unicharm beats BioHarvest Sciences on 10 of the 13 factors compared between the two stocks.

About BioHarvest Sciences

BioHarvest Sciences Inc. is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications. BioHarvest Sciences Inc. is based in Vancouver, Canada.

About Unicharm

Unicharm Corporation engages in the manufacturing and sale of wellness, feminine, baby and children, kirei, and pet care products in Japan and internationally. The company's baby and child care products, including disposable diapers and wipes under the Moony, MamyPoko, Oyasumiman, and Torepanman brands; feminine care products comprise napkins, tampons, panty liners, sanitary short, panty liners, and other feminine care products under the Sofy, Center-In, and Unicharm brand names; and wellness care products include napkin-type incontinence pads, pants-type diapers, tape-type diapers, pants-type specialized urine pads, and tape-type specialized urine pads under the Lifree and Charmnap brand. It also provides masks under the Unicharm brand; home care products, including cleaning sheets under the Wave brand name; cosmetic cotton and wet wipes under the Silcot brand; and paper towels under the Cook Up brand name. In addition, the company offers pet care products that include pet foods, excrement cleanup sheets, system toilets, and disposable diapers under the Grand Deli, Best Balance, Physicalife Dog, Silver Plate, Aiken Genki, Manner Wear, Deo Sheet, Silver Spoon, AllWell, Physicalife Cat, Deo Toilet, Deo Sand, Deo Clean, and Neko Genki brands; and deodorizing beads. Further, it is involved in the manufacture and sale of industrial materials related products, etc., as well as food-packaging materials. Unicharm Corporation was incorporated in 1941 and is headquartered in Tokyo, Japan.